Pangea Biomed

Risk score

57
Large logo of Pangea Biomed

Headquarters

Flag of IsraelIsrael

Pangea is revolutionizing the field of precision oncology and expanding accessibility to a larger pool of patients. Immunotherapy and precision oncology have a longstanding history, offering promise for individuals with cancer; however, fewer than 10 percent of cancer patients experience the benefits of current treatments. By harnessing the concealed potential of RNA sequencing alongside ML-driven network effects, our ENLIGHT platform has the ability to unveil pertinent biological understandings in order to identify the most effective approach to combat a patient's cancer.